Table 4 Results of this analysis with a large population size
Cardiovascular outcomes assessed | No of studies involved (n) | OR with 95% CI | P value | I2 value (%) |
|---|---|---|---|---|
Primary endpoint | 6 | 0.95 [0.86–1.04] | 0.26 | 65 |
Cardiovascular death | 5 | 1.00 [0.90–1.10] | 0.93 | 31 |
All-cause mortality | 6 | 0.84 [0.59–1.18] | 0.31 | 97 |
Stroke | 5 | 1.03 [0.89–1.18] | 0.72 | 0 |
Myocardial infarction | 5 | 0.97 [0.88–1.07] | 0.59 | 0 |
Hospitalization for cardiovascular complications | 4 | 1.02 [0.96–1.09] | 0.45 | 0 |
Hospitalization specifically for heart failure | 4 | 1.05 [0.90–1.23] | 0.55 | 64 |